242 related articles for article (PubMed ID: 15354402)
21. Free-from-progression period and overall short preoperative immunotherapy with IL-2 increases the survival of pancreatic cancer patients treated with macroscopically radical surgery.
Caprotti R; Brivio F; Fumagalli L; Nobili C; Degrate L; Lissoni P; Parolini D; Messina G; Colciago M; Scotti M; Uggeri F
Anticancer Res; 2008; 28(3B):1951-4. PubMed ID: 18630487
[TBL] [Abstract][Full Text] [Related]
22. Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients.
Lissoni P; Brivio F; Brivio O; Fumagalli L; Gramazio F; Rossi M; Emanuelli G; Alderi G; Lavorato F
J Biol Regul Homeost Agents; 1995; 9(1):31-3. PubMed ID: 8553906
[TBL] [Abstract][Full Text] [Related]
23. Immunodeficiency in radically operable gastric cancer patients.
Franciosi C; Bravo AF; Romano F; Fumagalli L; Cerea K; Conti M; Rovelli F; Uggeri F
Hepatogastroenterology; 2002; 49(45):857-9. PubMed ID: 12064007
[No Abstract] [Full Text] [Related]
24. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
[TBL] [Abstract][Full Text] [Related]
25. [Immunotherapy in radical surgery of colorectal carcinoma].
Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood lymphocyte changes after benign gastrointestinal surgery. Role of thymostimulin in reversing the postoperative immunodepression seen in humans.
Garcia-Valdecasas JC; Martinez A; Lopoez-Boado MA; de Lacy AM; Cugat E; Grande L; Fuster J; Visa J; Pera C
Hepatogastroenterology; 1988 Oct; 35(5):219-22. PubMed ID: 2976389
[TBL] [Abstract][Full Text] [Related]
27. Preoperative interleukin-2 immunotherapy in pancreatic cancer: preliminary results.
Angelini C; Bovo G; Muselli P; Mussi C; Crippa S; Caprotti R; Uggeri F
Hepatogastroenterology; 2006; 53(67):141-4. PubMed ID: 16506394
[TBL] [Abstract][Full Text] [Related]
28. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
[TBL] [Abstract][Full Text] [Related]
29. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.
Kuhlmann K; de Castro S; van Heek T; Busch O; van Gulik T; Obertop H; Gouma D
Surgery; 2006 Feb; 139(2):188-96. PubMed ID: 16455327
[TBL] [Abstract][Full Text] [Related]
30. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
[TBL] [Abstract][Full Text] [Related]
31. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
[TBL] [Abstract][Full Text] [Related]
32. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
33. Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity.
Whitson BA; D'Cunha J; Andrade RS; Kelly RF; Groth SS; Wu B; Miller JS; Kratzke RA; Maddaus MA
Ann Thorac Surg; 2008 Dec; 86(6):1735-44. PubMed ID: 19021967
[TBL] [Abstract][Full Text] [Related]
34. Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation.
Fernández-Ruiz M; López-Medrano F; Romo EM; Allende LM; Meneu JC; Fundora-Suárez Y; San-Juan R; Lizasoain M; Paz-Artal E; Aguado JM
Liver Transpl; 2009 Oct; 15(10):1209-16. PubMed ID: 19790140
[TBL] [Abstract][Full Text] [Related]
35. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer.
Bilimoria KY; Talamonti MS; Wayne JD; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
Arch Surg; 2008 Jul; 143(7):671-8; discussion 678. PubMed ID: 18645110
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
37. Correlation of altered blood albumin characteristics and lymphocyte populations to tumor stage in gastrointestinal cancer patients.
Kalnina I; Kurjane N; Kirilova E; Klimkane L; Kirilov G; Zvagule T
Cancer Biomark; 2010; 7(2):91-9. PubMed ID: 21178267
[TBL] [Abstract][Full Text] [Related]
38. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
Sierzega M; Popiela T; Kulig J; Nowak K
Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
[TBL] [Abstract][Full Text] [Related]
39. Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC.
Masotti A; Morandini G; Ortolani R; Fumagalli L
Lung Cancer; 1998 Jun; 20(3):191-202. PubMed ID: 9733054
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]